Envoy Medical (COCH) Cash from Operations (2021 - 2026)

Envoy Medical (COCH) has 6 years of Cash from Operations data on file, last reported at 6061000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 62.71% year-over-year to 6061000.0; the trailing twelve-month figure through Mar 2026 stood at 20537000.0 (down 27.68% YoY), and the FY2025 full-year result was 18201000.0, down 1.4% from the prior year.
• Cash from Operations declined to 6061000.0 in Q1 2026, from 5685000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 1099000.0 in Q3 2023 to a low of 11145000.0 in Q4 2023.
• A 5-year average of 4006294.12 and a median of 4331000.0 in 2025 frame the typical range for Cash from Operations.
• Peak annual rise in Cash from Operations reached 120.92% in 2023, while the deepest fall reached 908.1% in 2023.
• Tracing COCH's Cash from Operations over 5 years: stood at 2379000.0 in 2022, then tumbled by 368.47% to 11145000.0 in 2023, then jumped by 54.32% to 5091000.0 in 2024, then decreased by 11.67% to 5685000.0 in 2025, then declined by 6.61% to 6061000.0 in 2026.
• Business Quant data shows COCH's Cash from Operations at 6061000.0 in Q1 2026, 5685000.0 in Q4 2025, and 4331000.0 in Q3 2025.